IBP Module Invasive Blood Pressure ModuleRecalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884838020917), received between Sep 8, 2025 and Sep 8, 2025 — classified as 1 injury.

The most frequently reported specific device problem is “Incorrect Measurement” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjurySep 8, 2025Incorrect Measurement; Incorrect Measurement

  PHILIPS RECEIVED A COMPLAINT ON AN INVASIVE BLOOD PRESSURE MODULE. IT WAS REPORTED THE MONITOR DISPLAYED THE INCORRECT INTRACRANIAL PRESSURE (ICP); HOWEVER, IT WAS ALSO INDICATED THERE WAS NO HARM TO THE PATIENT. IT WAS ALSO STATED THERE WERE ADDITIONAL DRUGS ADMINISTERED BEYOND WHAT WAS EXPECTED FOR THE PROCEDURE, INCLUDING SEDATION, CURARE BOLUS, MANNITOL AND ADDITIONAL IV FLUID. THE PATIENT ALSO UNDERWENT MULTIPLE CT SCANS AND A CEREBRAL ULTRASOUND, WHICH CONFIRMED THE ICP VALUES HAD BEEN INCORRECT. THERE WERE NO CONSEQUENCES OR ACTUAL HARM TO THE PATIENT RELATED TO ALL THE DESCRIBED INTERVENTIONS AND THERE WAS NO CAUSE FOR THE REPORTED MALFUNCTION. BASED ON THE INFORMATION RECEIVED, IT APPEARS UNNECESSARY ADDITIONAL DRUGS WERE ADMINISTERED IN ADDITION TO EXTRA IMAGING. A MEDICATION ERROR, WHICH INCLUDES AN INCORRECT OR UNNECESSARY MEDICATION ADMINISTERED DUE TO AN ALLEGED DEVICE MALFUNCTION, WILL BE CONSIDERED A SERIOUS INJURY, AS MEDICAL INTERVENTION WAS PERFORMED TO PRECLUDE PERMANENT IMPAIRMENT OF A BODY FUNCTION OR PERMANENT DAMAGE TO BODY STRUCTURE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22994929 ↗